712 filings
Page 5 of 36
8-K
8p8n4j 5um4pkio3g3
14 Nov 22
Initiation of Phase 1/2a endometrial cancer trial expected in 1Q23; preliminary data expected 4Q23
4:20pm
4
4g92n
19 Aug 22
Onconova Therapeutics / JACK E STOVER ownership change
5:10pm
4
qx3iy3q
19 Aug 22
Onconova Therapeutics / JAMES J MARINO ownership change
4:59pm
4
999 0j7swvre
19 Aug 22
Onconova Therapeutics / VIREN MEHTA ownership change
4:57pm
4
xw8lqf01 w2u3wd
19 Aug 22
Onconova Therapeutics / Mary Teresa Shoemaker ownership change
4:55pm
4
ph1xfwlcni468r4pasz
19 Aug 22
Onconova Therapeutics / JEROME GROOPMAN ownership change
4:54pm
8-K
jtkr707t9q41lws
18 Aug 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
hybareota5 ffigt39ro
11 Aug 22
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
5:25pm
4
w0c j67n4o10r
4 Aug 22
Onconova Therapeutics / Mark Patrick Guerin ownership change
4:38pm
4
aqe15tu2
4 Aug 22
Onconova Therapeutics / Mark S. MD Gelder ownership change
4:34pm
4
l3m51zld
4 Aug 22
Onconova Therapeutics / Steven M Fruchtman ownership change
4:30pm
DEFA14A
9hqv9hs75 k7tqpscu
21 Jul 22
Additional proxy soliciting materials
4:35pm
8-K
5osrjjw2dni34 t9yeu
21 Jul 22
Other Events
4:32pm
4
gnriaf1yi
13 Jun 22
Onconova Therapeutics / Mark Patrick Guerin ownership change
4:03pm
8-K
ms8cfe8 vb
13 Jun 22
Onconova Therapeutics Announces Key Management Promotions
8:05am
8-K
cyo3py9
11 May 22
Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
4:07pm